Deciphering the shared genetic basis of distinct cancers has the potential to elucidate
carcinogenic mechanisms and inform broadly applicable risk assessment efforts. Here, we …

Genome-wide association studies (GWAS) have led to the identification of hundreds of
susceptibility loci across cancers, but the impact of further studies remains uncertain. Here …

B-cell non-Hodgkin's lymphoma (NHL) risk associations had been mainly attributed to family
history of the disease, inflammation, and immune components including human leukocyte …

We investigated whether genetic susceptibility to tuberculosis (TB) influences lung
adenocarcinoma development among never-smokers using TB genome-wide association …

Smoking is a major contributor to lung cancer and chronic obstructive pulmonary disease
(COPD). Two of the strongest genetic associations of smoking‐related phenotypes are the …

Genome‐wide association studies (GWAS) have identified 45 susceptibility loci associated
with lung cancer. Only less than SNPs, small insertions and deletions (INDELs) are the …

Genome-wide association studies (GWASs) have identified hundreds of single nucleotide
polymorphisms (SNPs) associated with cancer risk, several of which have shown pleiotropic …

Background: Relatives of patients with bladder cancer have been shown to be at increased
risk for kidney, lung, thyroid, and cervical cancer after correcting for smoking-related …

Background: A substantial proportion of cancer driver genes (CDG) are also cancer
predisposition genes. However, the associations between genetic variants in lung CDGs …

Lung cancer is the leading cause of cancer death worldwide. Genome-wide association
studies have revealed genetic risk factors, highlighting the role of smoking, family history …